aluates Reports

$ 0.0

Automative

Global Afamelanotide Market Research Report 2026

Published Date: 2026-01-14

Report Code: QYRE-Auto-0B16987

Global Afamelanotide Market Research Report 2024

BUY CHAPTERS

Global Afamelanotide Market Research Report 2026

Code: QYRE-Auto-0B16987

Report

2026-01-14

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Clinuvel Pharmaceuticals

Evonik Industries

Hangzhou Go Top Peptide Biotech

Zhejiang Hengtengfu

Wepon

Afamelanotide Market Size

The global Afamelanotide market was valued at US$ 67.80 million in 2025 and is anticipated to reach US$ 114 million by 2032, at a CAGR of 7.8% from 2026 to 2032.

Afamelanotide Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Afamelanotide competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Afamelanotide is a synthetic peptide drug, an analog of alpha-melanocyte-stimulating hormone (α-MSH), used as a subcutaneous implant to prevent painful skin reactions from sun exposure in patients with the rare genetic disorder Erythropoietic Protoporphyria (EPP). It works by stimulating melanin (specifically eumelanin) production in the skin, which blocks light and reduces the severe pain, redness, and swelling caused by EPP. Administered as a small implant under the skin, it's released slowly over about two months.

Global production of afanotide is projected to reach 3,000 vials by 2025, with an average price of US$22,600 per vial. Gross profit margins typically remain at a high level of 70% to 85%.

Afamelanotide is a synthetic analog of melanocyte-stimulating hormone. Its upstream industry chain mainly consists of peptide raw materials and amino acid monomers, solid-phase synthesis resins and reagents, solvents, lyophilization excipients, sterile packaging materials, and bioanalytical testing services. The upstream focus lies in high-purity peptide synthesis and consistent quality control. Downstream demand is highly concentrated in rare disease and niche dermatology treatments, with its primary use in improving phototolerance for patients with erythropoietic protoporphyria. End users are mainly specialized hospitals, rare disease treatment centers, and reimbursement systems. Given the small and clearly defined patient population, downstream stakeholders prioritize clinical efficacy, safety, ease of administration, and long-term adherence. Payment is often supported by public insurance, special funds, or premium commercial insurance, resulting in relatively low price sensitivity but high requirements for clinical evidence. As real-world data accumulates, downstream applications are gradually expanding toward additional photosensitivity-related indications, while remaining focused on specialist channels and academic promotion.

In terms of industry trends, Afamelanotide products are moving toward indication expansion, optimized delivery methods, and stronger real-world evidence generation. Key growth drivers include supportive orphan drug policies, incentives for rare disease development, and increasing advocacy from patient organizations. Major constraints include a limited patient base that caps market size, high development and regulatory costs, complex manufacturing barriers, and strong dependence on a single core product.

This report delivers a comprehensive overview of the global Afamelanotide market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Afamelanotide. The Afamelanotide market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Afamelanotide market comprehensively. Regional market sizes by Type, by Application, by Chemical Structure, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Afamelanotide manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Afamelanotide Market Report

Report Metric	Details
Report Name	Afamelanotide Market
Accounted market size in 2025	US$ 67.80 million
Forecasted market size in 2032	US$ 114 million
CAGR	7.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Subcutaneous Implants Injectables Transdermal Patches Oral Preparations Topical Preparations
Segment by Chemical Structure	Α-MSH Analogs Acetate Derivatives Free Peptide Derivatives Long-Acting Modified Derivatives
Segment by Pharmacological Effects	MC1R Selective Agonists Melanin Synthesis Stimulants Anti-Inflammatory Agents Neuroprotective Agents
by Application	Hematologic Disorders Skin Pigmentary Disorders Acute Diseases Autoimmune Diseases Neurodegenerative Diseases
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Clinuvel Pharmaceuticals, Evonik Industries, Hangzhou Go Top Peptide Biotech, Zhejiang Hengtengfu, Wepon
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Chemical Structure, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Afamelanotide manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Afamelanotide sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Afamelanotide Market growing?

Ans: The Afamelanotide Market witnessing a CAGR of 7.8% during the forecast period 2026-2032.

What is the Afamelanotide Market size in 2032?

Ans: The Afamelanotide Market size in 2032 will be US$ 114 million.

Who are the main players in the Afamelanotide Market report?

Ans: The main players in the Afamelanotide Market are Clinuvel Pharmaceuticals, Evonik Industries, Hangzhou Go Top Peptide Biotech, Zhejiang Hengtengfu, Wepon

What are the Application segmentation covered in the Afamelanotide Market report?

Ans: The Applications covered in the Afamelanotide Market report are Hematologic Disorders, Skin Pigmentary Disorders, Acute Diseases, Autoimmune Diseases, Neurodegenerative Diseases

What are the Type segmentation covered in the Afamelanotide Market report?

Ans: The Types covered in the Afamelanotide Market report are Subcutaneous Implants, Injectables, Transdermal Patches, Oral Preparations, Topical Preparations

1 Afamelanotide Market Overview

1.1 Product Definition

1.2 Afamelanotide by Type

1.2.1 Global Afamelanotide Market Value by Type: 2025 vs 2032

1.2.2 Subcutaneous Implants

1.2.3 Injectables

1.2.4 Transdermal Patches

1.2.5 Oral Preparations

1.2.6 Topical Preparations

1.3 Afamelanotide by Chemical Structure

1.3.1 Global Afamelanotide Market Value by Chemical Structure: 2025 vs 2032

1.3.2 Α-MSH Analogs

1.3.3 Acetate Derivatives

1.3.4 Free Peptide Derivatives

1.3.5 Long-Acting Modified Derivatives

1.4 Afamelanotide by Pharmacological Effects

1.4.1 Global Afamelanotide Market Value by Pharmacological Effects: 2025 vs 2032

1.4.2 MC1R Selective Agonists

1.4.3 Melanin Synthesis Stimulants

1.4.4 Anti-Inflammatory Agents

1.4.5 Neuroprotective Agents

1.5 Afamelanotide by Application

1.5.1 Global Afamelanotide Market Value by Application: 2025 vs 2032

1.5.2 Hematologic Disorders

1.5.3 Skin Pigmentary Disorders

1.5.4 Acute Diseases

1.5.5 Autoimmune Diseases

1.5.6 Neurodegenerative Diseases

1.6 Global Afamelanotide Market Size Estimates and Forecasts

1.6.1 Global Afamelanotide Revenue 2021–2032

1.6.2 Global Afamelanotide Sales 2021–2032

1.6.3 Global Afamelanotide Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Afamelanotide Market Competition by Manufacturers

2.1 Global Afamelanotide Sales Market Share by Manufacturers (2021–2026)

2.2 Global Afamelanotide Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Afamelanotide Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Afamelanotide, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Afamelanotide, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Afamelanotide, Product Types and Applications

2.7 Global Key Manufacturers of Afamelanotide, Date of Entry into the Industry

2.8 Global Afamelanotide Market Competitive Situation and Trends

2.8.1 Global Afamelanotide Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Afamelanotide Players Market Share by Revenue

2.8.3 Global Afamelanotide Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Afamelanotide Market Scenario by Region

3.1 Global Afamelanotide Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Afamelanotide Sales by Region: 2021–2032

3.2.1 Global Afamelanotide Sales by Region: 2021–2026

3.2.2 Global Afamelanotide Sales by Region: 2027–2032

3.3 Global Afamelanotide Revenue by Region: 2021–2032

3.3.1 Global Afamelanotide Revenue by Region: 2021–2026

3.3.2 Global Afamelanotide Revenue by Region: 2027–2032

3.4 North America Afamelanotide Market Facts & Figures by Country

3.4.1 North America Afamelanotide Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Afamelanotide Sales by Country (2021–2032)

3.4.3 North America Afamelanotide Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Afamelanotide Market Facts & Figures by Country

3.5.1 Europe Afamelanotide Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Afamelanotide Sales by Country (2021–2032)

3.5.3 Europe Afamelanotide Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Afamelanotide Market Facts & Figures by Region

3.6.1 Asia Pacific Afamelanotide Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Afamelanotide Sales by Region (2021–2032)

3.6.3 Asia Pacific Afamelanotide Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Afamelanotide Market Facts & Figures by Country

3.7.1 Latin America Afamelanotide Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Afamelanotide Sales by Country (2021–2032)

3.7.3 Latin America Afamelanotide Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Afamelanotide Market Facts & Figures by Country

3.8.1 Middle East and Africa Afamelanotide Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Afamelanotide Sales by Country (2021–2032)

3.8.3 Middle East and Africa Afamelanotide Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Afamelanotide Sales by Type (2021–2032)

4.1.1 Global Afamelanotide Sales by Type (2021–2026)

4.1.2 Global Afamelanotide Sales by Type (2027–2032)

4.1.3 Global Afamelanotide Sales Market Share by Type (2021–2032)

4.2 Global Afamelanotide Revenue by Type (2021–2032)

4.2.1 Global Afamelanotide Revenue by Type (2021–2026)

4.2.2 Global Afamelanotide Revenue by Type (2027–2032)

4.2.3 Global Afamelanotide Revenue Market Share by Type (2021–2032)

4.3 Global Afamelanotide Price by Type (2021–2032)

5 Segment by Application

5.1 Global Afamelanotide Sales by Application (2021–2032)

5.1.1 Global Afamelanotide Sales by Application (2021–2026)

5.1.2 Global Afamelanotide Sales by Application (2027–2032)

5.1.3 Global Afamelanotide Sales Market Share by Application (2021–2032)

5.2 Global Afamelanotide Revenue by Application (2021–2032)

5.2.1 Global Afamelanotide Revenue by Application (2021–2026)

5.2.2 Global Afamelanotide Revenue by Application (2027–2032)

5.2.3 Global Afamelanotide Revenue Market Share by Application (2021–2032)

5.3 Global Afamelanotide Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Clinuvel Pharmaceuticals

6.1.1 Clinuvel Pharmaceuticals Company Information

6.1.2 Clinuvel Pharmaceuticals Description and Business Overview

6.1.3 Clinuvel Pharmaceuticals Afamelanotide Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Clinuvel Pharmaceuticals Afamelanotide Product Portfolio

6.1.5 Clinuvel Pharmaceuticals Recent Developments/Updates

6.2 Evonik Industries

6.2.1 Evonik Industries Company Information

6.2.2 Evonik Industries Description and Business Overview

6.2.3 Evonik Industries Afamelanotide Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Evonik Industries Afamelanotide Product Portfolio

6.2.5 Evonik Industries Recent Developments/Updates

6.3 Hangzhou Go Top Peptide Biotech

6.3.1 Hangzhou Go Top Peptide Biotech Company Information

6.3.2 Hangzhou Go Top Peptide Biotech Description and Business Overview

6.3.3 Hangzhou Go Top Peptide Biotech Afamelanotide Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Hangzhou Go Top Peptide Biotech Afamelanotide Product Portfolio

6.3.5 Hangzhou Go Top Peptide Biotech Recent Developments/Updates

6.4 Zhejiang Hengtengfu

6.4.1 Zhejiang Hengtengfu Company Information

6.4.2 Zhejiang Hengtengfu Description and Business Overview

6.4.3 Zhejiang Hengtengfu Afamelanotide Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Zhejiang Hengtengfu Afamelanotide Product Portfolio

6.4.5 Zhejiang Hengtengfu Recent Developments/Updates

6.5 Wepon

6.5.1 Wepon Company Information

6.5.2 Wepon Description and Business Overview

6.5.3 Wepon Afamelanotide Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Wepon Afamelanotide Product Portfolio

6.5.5 Wepon Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Afamelanotide Industry Chain Analysis

7.2 Afamelanotide Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Afamelanotide Production Mode & Process Analysis

7.4 Afamelanotide Sales and Marketing

7.4.1 Afamelanotide Sales Channels

7.4.2 Afamelanotide Distributors

7.5 Afamelanotide Customer Analysis

8 Afamelanotide Market Dynamics

8.1 Afamelanotide Industry Trends

8.2 Afamelanotide Market Drivers

8.3 Afamelanotide Market Challenges

8.4 Afamelanotide Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Clinuvel Pharmaceuticals

Evonik Industries

Hangzhou Go Top Peptide Biotech

Zhejiang Hengtengfu

Wepon

List of Tables

Table 1. Global Afamelanotide Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Afamelanotide Market Value by Chemical Structure (US$ Million), 2025 vs 2032

Table 3. Global Afamelanotide Market Value by Pharmacological Effects (US$ Million), 2025 vs 2032

Table 4. Global Afamelanotide Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Afamelanotide Market Competitive Situation by Manufacturers in 2025

Table 6. Global Afamelanotide Sales (Units) of Key Manufacturers (2021–2026)

Table 7. Global Afamelanotide Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Afamelanotide Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Afamelanotide Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Afamelanotide Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Afamelanotide, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Afamelanotide, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Afamelanotide, Product Types and Applications

Table 14. Global Key Manufacturers of Afamelanotide, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Afamelanotide Companies by Tier (Tier 1, Tier 2, Tier 3), based on Afamelanotide Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Afamelanotide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Afamelanotide Sales by Region (Units), 2021–2026

Table 20. Global Afamelanotide Sales Market Share by Region (2021–2026)

Table 21. Global Afamelanotide Sales by Region (Units), 2027–2032

Table 22. Global Afamelanotide Sales Market Share by Region (2027–2032)

Table 23. Global Afamelanotide Revenue by Region (US$ Million), 2021–2026

Table 24. Global Afamelanotide Revenue Market Share by Region (2021–2026)

Table 25. Global Afamelanotide Revenue by Region (US$ Million), 2027–2032

Table 26. Global Afamelanotide Revenue Market Share by Region (2027–2032)

Table 27. North America Afamelanotide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Afamelanotide Sales by Country (Units), 2021–2026

Table 29. North America Afamelanotide Sales by Country (Units), 2027–2032

Table 30. North America Afamelanotide Revenue by Country (US$ Million), 2021–2026

Table 31. North America Afamelanotide Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Afamelanotide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Afamelanotide Sales by Country (Units), 2021–2026

Table 34. Europe Afamelanotide Sales by Country (Units), 2027–2032

Table 35. Europe Afamelanotide Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Afamelanotide Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Afamelanotide Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Afamelanotide Sales by Region (Units), 2021–2026

Table 39. Asia Pacific Afamelanotide Sales by Region (Units), 2027–2032

Table 40. Asia Pacific Afamelanotide Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Afamelanotide Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Afamelanotide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Afamelanotide Sales by Country (Units), 2021–2026

Table 44. Latin America Afamelanotide Sales by Country (Units), 2027–2032

Table 45. Latin America Afamelanotide Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Afamelanotide Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Afamelanotide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Afamelanotide Sales by Country (Units), 2021–2026

Table 49. Middle East and Africa Afamelanotide Sales by Country (Units), 2027–2032

Table 50. Middle East and Africa Afamelanotide Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Afamelanotide Revenue by Country (US$ Million), 2027–2032

Table 52. Global Afamelanotide Sales (Units) by Type (2021–2026)

Table 53. Global Afamelanotide Sales (Units) by Type (2027–2032)

Table 54. Global Afamelanotide Sales Market Share by Type (2021–2026)

Table 55. Global Afamelanotide Sales Market Share by Type (2027–2032)

Table 56. Global Afamelanotide Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Afamelanotide Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Afamelanotide Revenue Market Share by Type (2021–2026)

Table 59. Global Afamelanotide Revenue Market Share by Type (2027–2032)

Table 60. Global Afamelanotide Price (US$/Unit) by Type (2021–2026)

Table 61. Global Afamelanotide Price (US$/Unit) by Type (2027–2032)

Table 62. Global Afamelanotide Sales (Units) by Application (2021–2026)

Table 63. Global Afamelanotide Sales (Units) by Application (2027–2032)

Table 64. Global Afamelanotide Sales Market Share by Application (2021–2026)

Table 65. Global Afamelanotide Sales Market Share by Application (2027–2032)

Table 66. Global Afamelanotide Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Afamelanotide Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Afamelanotide Revenue Market Share by Application (2021–2026)

Table 69. Global Afamelanotide Revenue Market Share by Application (2027–2032)

Table 70. Global Afamelanotide Price (US$/Unit) by Application (2021–2026)

Table 71. Global Afamelanotide Price (US$/Unit) by Application (2027–2032)

Table 72. Clinuvel Pharmaceuticals Company Information

Table 73. Clinuvel Pharmaceuticals Description and Business Overview

Table 74. Clinuvel Pharmaceuticals Afamelanotide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. Clinuvel Pharmaceuticals Afamelanotide Product

Table 76. Clinuvel Pharmaceuticals Recent Developments/Updates

Table 77. Evonik Industries Company Information

Table 78. Evonik Industries Description and Business Overview

Table 79. Evonik Industries Afamelanotide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Evonik Industries Afamelanotide Product

Table 81. Evonik Industries Recent Developments/Updates

Table 82. Hangzhou Go Top Peptide Biotech Company Information

Table 83. Hangzhou Go Top Peptide Biotech Description and Business Overview

Table 84. Hangzhou Go Top Peptide Biotech Afamelanotide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. Hangzhou Go Top Peptide Biotech Afamelanotide Product

Table 86. Hangzhou Go Top Peptide Biotech Recent Developments/Updates

Table 87. Zhejiang Hengtengfu Company Information

Table 88. Zhejiang Hengtengfu Description and Business Overview

Table 89. Zhejiang Hengtengfu Afamelanotide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. Zhejiang Hengtengfu Afamelanotide Product

Table 91. Zhejiang Hengtengfu Recent Developments/Updates

Table 92. Wepon Company Information

Table 93. Wepon Description and Business Overview

Table 94. Wepon Afamelanotide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 95. Wepon Afamelanotide Product

Table 96. Wepon Recent Developments/Updates

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Afamelanotide Distributors List

Table 100. Afamelanotide Customers List

Table 101. Afamelanotide Market Trends

Table 102. Afamelanotide Market Drivers

Table 103. Afamelanotide Market Challenges

Table 104. Afamelanotide Market Restraints

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

Table 108. Authors List of This Report

List of Figures

Figure 1. Product Picture of Afamelanotide

Figure 2. Global Afamelanotide Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Afamelanotide Market Share by Type: 2025 & 2032

Figure 4. Subcutaneous Implants Product Picture

Figure 5. Injectables Product Picture

Figure 6. Transdermal Patches Product Picture

Figure 7. Oral Preparations Product Picture

Figure 8. Topical Preparations Product Picture

Figure 9. Global Afamelanotide Market Value by Chemical Structure (US$ Million), 2021–2032

Figure 10. Global Afamelanotide Market Share by Chemical Structure: 2025 vs 2032

Figure 11. Α-MSH Analogs Product Picture

Figure 12. Acetate Derivatives Product Picture

Figure 13. Free Peptide Derivatives Product Picture

Figure 14. Long-Acting Modified Derivatives Product Picture

Figure 15. Global Afamelanotide Market Value by Pharmacological Effects (US$ Million), 2021–2032

Figure 16. Global Afamelanotide Market Share by Pharmacological Effects: 2025 vs 2032

Figure 17. MC1R Selective Agonists Product Picture

Figure 18. Melanin Synthesis Stimulants Product Picture

Figure 19. Anti-Inflammatory Agents Product Picture

Figure 20. Neuroprotective Agents Product Picture

Figure 21. Global Afamelanotide Market Value by Application (US$ Million), 2021–2032

Figure 22. Global Afamelanotide Market Share by Application: 2025 & 2032

Figure 23. Hematologic Disorders

Figure 24. Skin Pigmentary Disorders

Figure 25. Acute Diseases

Figure 26. Autoimmune Diseases

Figure 27. Neurodegenerative Diseases

Figure 28. Global Afamelanotide Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 29. Global Afamelanotide Market Size (US$ Million), 2021–2032

Figure 30. Global Afamelanotide Sales (Units), 2021–2032

Figure 31. Global Afamelanotide Average Price (US$/Unit), 2021–2032

Figure 32. Afamelanotide Report Years Considered

Figure 33. Afamelanotide Sales Share by Manufacturers in 2025

Figure 34. Global Afamelanotide Revenue Share by Manufacturers in 2025

Figure 35. Top 5 and Top 10 Global Afamelanotide Players: Market Share by Revenue in Afamelanotide in 2025

Figure 36. Afamelanotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 37. Global Afamelanotide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 38. North America Afamelanotide Sales Market Share by Country (2021–2032)

Figure 39. North America Afamelanotide Revenue Market Share by Country (2021–2032)

Figure 40. United States Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Canada Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Europe Afamelanotide Sales Market Share by Country (2021–2032)

Figure 43. Europe Afamelanotide Revenue Market Share by Country (2021–2032)

Figure 44. Germany Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. France Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. U.K. Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Italy Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Russia Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Asia Pacific Afamelanotide Sales Market Share by Region (2021–2032)

Figure 50. Asia Pacific Afamelanotide Revenue Market Share by Region (2021–2032)

Figure 51. China Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Japan Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. South Korea Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. India Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Australia Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. China Taiwan Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Southeast Asia Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Latin America Afamelanotide Sales Market Share by Country (2021–2032)

Figure 59. Latin America Afamelanotide Revenue Market Share by Country (2021–2032)

Figure 60. Mexico Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Brazil Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. Argentina Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. Middle East and Africa Afamelanotide Sales Market Share by Country (2021–2032)

Figure 64. Middle East and Africa Afamelanotide Revenue Market Share by Country (2021–2032)

Figure 65. Turkey Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 66. Saudi Arabia Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 67. UAE Afamelanotide Revenue Growth Rate (US$ Million), 2021–2032

Figure 68. Global Sales Market Share of Afamelanotide by Type (2021–2032)

Figure 69. Global Revenue Market Share of Afamelanotide by Type (2021–2032)

Figure 70. Global Afamelanotide Price (US$/Unit) by Type (2021–2032)

Figure 71. Global Sales Market Share of Afamelanotide by Application (2021–2032)

Figure 72. Global Revenue Market Share of Afamelanotide by Application (2021–2032)

Figure 73. Global Afamelanotide Price (US$/Unit) by Application (2021–2032)

Figure 74. Afamelanotide Value Chain

Figure 75. Channels of Distribution (Direct Vs Distribution)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Fostamatinib Market Research Report 2024

Global Lanreotide Acetate Market Research Report 2025

Global Linaclotide Market Insights Forecast to 2030

Global Anlotinib Market Research Report 2024

Bremelanotide API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Peptide Therapeutics Market Research Report 2024

Fostamatinib Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Asparagine Market Research Report 2024

Global Afatinib Maleate Tablets Market Research Report 2024

Global Tofacitinib Market Research Report 2024

Global Sandostatin Market Research Report 2024

Global Silk Peptide Market Research Report 2024

Global Malonamide Market Research Report 2025

Global Apatinib Market Research Report 2024

Global Flumetralin Market Research Report 2025

Global Peptide API Market Research Report 2024

Global Amivantamab Market Research Report 2024

Global Peptide Analysis Market Research Report 2025

Global Melphalan Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions